"Administration, Ophthalmic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Application of pharmaceutically active agents on the tissues of the EYE.
- Administration, Ophthalmic
- Administrations, Ophthalmic
- Ophthalmic Administration
- Ophthalmic Administrations
- Ocular Administration
- Administration, Ocular
- Administrations, Ocular
- Ocular Administrations
Below are MeSH descriptors whose meaning is more general than "Administration, Ophthalmic".
Below are MeSH descriptors whose meaning is more specific than "Administration, Ophthalmic".
This graph shows the total number of publications written about "Administration, Ophthalmic" by people in this website by year, and whether "Administration, Ophthalmic" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Administration, Ophthalmic" by people in Profiles.
Antimicrobial Peptides Derived from the Immune Defense Protein CAP37 Inhibit TLR4 Activation by S100A9. Invest Ophthalmol Vis Sci. 2020 04 09; 61(4):16.
Topical Formulation of Self-Assembled Antiviral Prodrug Nanomicelles for Targeted Retinal Delivery. Mol Pharm. 2017 06 05; 14(6):2056-2069.
Long-term consequences of topical dexamethasone treatment during acute corneal HSV-1 infection on the immune system. J Leukoc Biol. 2017 05; 101(5):1253-1261.
A comprehensive insight on ocular pharmacokinetics. Drug Deliv Transl Res. 2016 12; 6(6):735-754.
Nanoparticle-Based Topical Ophthalmic Gel Formulation for Sustained Release of Hydrocortisone Butyrate. AAPS PharmSciTech. 2016 Apr; 17(2):294-306.
Nanoparticle-based topical ophthalmic formulation for sustained release of stereoisomeric dipeptide prodrugs of ganciclovir. Drug Deliv. 2016 Sep; 23(7):2399-2409.
Novel intraocular and systemic absorption drug delivery and efficacy of N-acetylcarnosine lubricant eye drops or carcinine biologics in pharmaceutical usage and therapeutic vision care. Fundam Clin Pharmacol. 2012 Oct; 26(5):644-78.